Literature DB >> 8582214

[Local arterial infusion of 5-FU in treatment of acute necrotic pancreatitis].

F Gu1, Y Liu, R Pan.   

Abstract

In 19 patients with acute necrotic pancreatitis the cordis tube was inserted in the arterial suppling blood. If the necrotic site at the head of pancreata, the tube was placed in the arteria gastroduodenalis or arteria pancreaticoduodenalis. When the site at the trunk or rearby, the tube was placed in the arteria lienalis or coeliaca, and when the necrosis all over the pancreata, the tube in the arteria coeliaca. Through the tube, infusion drugs mainly 5-FU were given within 20 days from onset of the disease. Compared with the controlled group of 68 patients, the mortalities were 10.5% and 30.9%, and the rates of organ falls 5.3% and 42.7%. The second infection of bacterium was 5.3% and 44.1% respectively. We suggest that local arterial infusion of 5-FU is an effective treatment for acute necrotic pancreatitis and creats conditions for delayed operations, clears the remaining tissue of necrotic pancreatitis easily.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582214

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  3 in total

1.  Treatment of abdominal compartment syndrome in severe acute pancreatitis patients with traditional Chinese medicine.

Authors:  Min-Jie Zhang; Guo-Lei Zhang; Wen-Bin Yuan; Jun Ni; Li-Feng Huang
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

2.  Effect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitis.

Authors:  Xiao-Li Chen; Sang-Zhu Ciren; Hui Zhang; Li-Geng Duan; Alexander J Wesley
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

3.  Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model.

Authors:  Meng Tao Zhou; Bi Cheng Chen; Hong Wei Sun; Yue Peng Jin; Fa Jing Yang; Xing Zhang; Roland Andersson; Qi Yu Zhang
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.